Venture Global (NYSE: VG) and Edison settle Calcasieu Pass arbitration, agree to expand LNG deliveries to Italy
Herald Investment Trust (LSE: HRI) board races to build cash war chest as Saba standoff stretches into spring
ABIONYX Pharma (ABNX) achieves sphingomyelin manufacturing breakthrough to advance CER-001 sepsis program
Read More 5 minute read Pharma Industry News Top 5 PCSK9 inhibitor stocks to watch in 2025: From injectables to gene editing Explore the top five PCSK9 inhibitor stocks—Amgen, Regeneron–Sanofi, Merck, Novartis, Verve—and what makes each a standout in cholesterol treatment in 2025. byPallavi MadhirajuJune 11, 2025